We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why Veeva Systems (VEEV) Dipped More Than Broader Market Today
Read MoreHide Full Article
Veeva Systems (VEEV - Free Report) closed the most recent trading day at $291.70, moving -1.77% from the previous trading session. This change lagged the S&P 500's daily loss of 1.66%. Meanwhile, the Dow experienced a drop of 1.65%, and the technology-dominated Nasdaq saw a decrease of 2.29%.
The provider of cloud-based software services for the life sciences industry's stock has climbed by 3.33% in the past month, falling short of the Medical sector's gain of 6.4% and the S&P 500's gain of 4.64%.
The investment community will be closely monitoring the performance of Veeva Systems in its forthcoming earnings report. The company is scheduled to release its earnings on November 20, 2025. On that day, Veeva Systems is projected to report earnings of $1.95 per share, which would represent year-over-year growth of 11.43%. Our most recent consensus estimate is calling for quarterly revenue of $791.88 million, up 13.25% from the year-ago period.
For the full year, the Zacks Consensus Estimates project earnings of $7.78 per share and a revenue of $3.14 billion, demonstrating changes of +17.88% and +14.26%, respectively, from the preceding year.
Investors should also note any recent changes to analyst estimates for Veeva Systems. These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. Veeva Systems is currently sporting a Zacks Rank of #2 (Buy).
Looking at valuation, Veeva Systems is presently trading at a Forward P/E ratio of 38.18. This expresses a premium compared to the average Forward P/E of 34.81 of its industry.
Investors should also note that VEEV has a PEG ratio of 1.63 right now. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The Medical Info Systems industry currently had an average PEG ratio of 3.09 as of yesterday's close.
The Medical Info Systems industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 72, placing it within the top 30% of over 250 industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Why Veeva Systems (VEEV) Dipped More Than Broader Market Today
Veeva Systems (VEEV - Free Report) closed the most recent trading day at $291.70, moving -1.77% from the previous trading session. This change lagged the S&P 500's daily loss of 1.66%. Meanwhile, the Dow experienced a drop of 1.65%, and the technology-dominated Nasdaq saw a decrease of 2.29%.
The provider of cloud-based software services for the life sciences industry's stock has climbed by 3.33% in the past month, falling short of the Medical sector's gain of 6.4% and the S&P 500's gain of 4.64%.
The investment community will be closely monitoring the performance of Veeva Systems in its forthcoming earnings report. The company is scheduled to release its earnings on November 20, 2025. On that day, Veeva Systems is projected to report earnings of $1.95 per share, which would represent year-over-year growth of 11.43%. Our most recent consensus estimate is calling for quarterly revenue of $791.88 million, up 13.25% from the year-ago period.
For the full year, the Zacks Consensus Estimates project earnings of $7.78 per share and a revenue of $3.14 billion, demonstrating changes of +17.88% and +14.26%, respectively, from the preceding year.
Investors should also note any recent changes to analyst estimates for Veeva Systems. These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. Veeva Systems is currently sporting a Zacks Rank of #2 (Buy).
Looking at valuation, Veeva Systems is presently trading at a Forward P/E ratio of 38.18. This expresses a premium compared to the average Forward P/E of 34.81 of its industry.
Investors should also note that VEEV has a PEG ratio of 1.63 right now. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The Medical Info Systems industry currently had an average PEG ratio of 3.09 as of yesterday's close.
The Medical Info Systems industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 72, placing it within the top 30% of over 250 industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.